User profiles for Roger D. Kouyos

Roger D. Kouyos

University of Zurich; University Hospital Zurich
Verified email at uzh.ch
Cited by 8138

Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection

RD Kouyos, V von Wyl, S Yerly, J Böni… - Clinical infectious …, 2011 - academic.oup.com
Background. The time passed since the infection of a human immunodeficiency virus (HIV)–infected
individual (the age of infection) is an important but often only poorly known quantity. …

Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland

RD Kouyos, V Von Wyl, S Yerly, J Böni… - The Journal of …, 2010 - academic.oup.com
Background . Sequence data from resistance testing offer unique opportunities to characterize
the structure of human immunodeficiency virus (HIV) infection epidemics. Methods . We …

Exploring the complexity of the HIV-1 fitness landscape

RD Kouyos, GE Leventhal, T Hinkley, M Haddad… - PLoS …, 2012 - journals.plos.org
Although fitness landscapes are central to evolutionary theory, so far no biologically realistic
examples for large-scale fitness landscapes have been described. Most currently available …

Epistasis between deleterious mutations and the evolution of recombination

RD Kouyos, OK Silander, S Bonhoeffer - Trends in ecology & evolution, 2007 - cell.com
Epistasis and the evolution of recombination are closely intertwined: epistasis generates
linkage disequilibria (ie statistical associations between alleles), whereas recombination …

Stochastic or deterministic: what is the effective population size of HIV-1?

RD Kouyos, CL Althaus, S Bonhoeffer - Trends in microbiology, 2006 - cell.com
Various studies have attempted to estimate the effective population size of HIV-1 to determine
the strength of stochastic effects in within-host evolution. The largely discrepant estimates, …

Determinants of HIV-1 broadly neutralizing antibody induction

P Rusert, RD Kouyos, C Kadelka, H Ebner, M Schanz… - Nature medicine, 2016 - nature.com
Broadly neutralizing antibodies (bnAbs) are a focal component of HIV-1 vaccine design, yet
basic aspects of their induction remain poorly understood. Here we report on viral, host and …

Tracing HIV-1 strains that imprint broadly neutralizing antibody responses

RD Kouyos, P Rusert, C Kadelka, M Huber, A Marzel… - Nature, 2018 - nature.com
Understanding the determinants of broadly neutralizing antibody (bNAb) evolution is crucial
for the development of bNAb-based HIV vaccines 1 . Despite emerging information on …

A highly virulent variant of HIV-1 circulating in the Netherlands

…, HF Günthard, P Kivelä, RD Kouyos… - Science, 2022 - science.org
We discovered a highly virulent variant of subtype-B HIV-1 in the Netherlands. One hundred
nine individuals with this variant had a 0.54 to 0.74 log 10 increase (ie, a ~3.5-fold to 5.5-…

Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance

…, ES Svarovskaia, H Mo, RD Kouyos… - Proceedings of the …, 2011 - National Acad Sciences
The development of resistance to direct-acting antivirals (DAAs) targeting the hepatitis C
virus (HCV) can compromise therapy. However, mechanisms that determine prevalence and …

Cohort profile update: the Swiss HIV cohort study (SHCS)

…, C Kahlert, A Trkola, RD Kouyos… - International journal …, 2022 - academic.oup.com
The Swiss HIV Cohort Study (SHCS) provides a unique research platform for clinical,
translational, epidemiological, social and basic research. The SHCS was established in 1988. It is …